Intuitive Surgical - ISRG Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $396.17
Forecasted Upside: 5.50%
Number of Analysts: 17
Breakdown:
0 Sell Ratings
4 Hold Ratings
13 Buy Ratings
0 Strong Buy Ratings

^$375.53 As of 04/26/2024 12:45 PM ET

▲ +2.41 (0.65%)

1 month | 3 months | 12 months

Get New Intuitive Surgical Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ISRG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISRG

^$396.17

▲ +5.50% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $396.17, with a high forecast of $462.00 and a low forecast of $314.00. The average price target represents a 5.50% upside from the last price of $375.53.

Current Consensus is Moderate Buy

The current consensus among 17 investment analysts is to moderate buy stock in Intuitive Surgical. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

11/2/2022

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/31/2023

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

5/1/2023

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/30/2023

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/28/2023

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/26/2024

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/26/2024

0 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/25/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/19/2024	Piper Sandler	Boost Target	Overweight ➝ Overweight	$425.00 ➝ $435.00	Low
4/19/2024	BTIG Research	Boost Target	Buy ➝ Buy	$412.00 ➝ $421.00	Low
4/19/2024	Robert W. Baird	Lower Target	Outperform ➝ Outperform	$440.00 ➝ $436.00	Low
4/19/2024	Jefferies Financial Group	Boost Target	Hold ➝ Hold	$365.00 ➝ $375.00	Low
4/8/2024	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$420.00 ➝ $430.00	Low
4/3/2024	Citigroup	Boost Target	Buy ➝ Buy	$428.00 ➝ $462.00	Low
3/15/2024	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$420.00	Low
1/25/2024	Mizuho	Boost Target	Neutral ➝ Neutral	$350.00 ➝ $390.00	Low
1/25/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$372.00 ➝ $435.00	Low
1/25/2024	Barclays	Boost Target	Overweight ➝ Overweight	$385.00 ➝ $430.00	Low
1/24/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$400.00 ➝ $432.00	Low
1/24/2024	Truist Financial	Boost Target	Buy ➝ Buy	$390.00 ➝ $435.00	Low
1/24/2024	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$360.00 ➝ $420.00	Low
1/24/2024	Piper Sandler	Boost Target	Overweight ➝ Overweight	$325.00 ➝ $425.00	Low
1/19/2024	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$363.00 ➝ $416.00	Low
1/12/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$380.00 ➝ $400.00	Low
1/3/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$310.00 ➝ $372.00	Low
12/22/2023	Truist Financial	Boost Target	Buy ➝ Buy	$375.00 ➝ $390.00	Low
12/12/2023	Truist Financial	Boost Target	Buy ➝ Buy	$320.00 ➝ $375.00	Low
12/4/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$300.00 ➝ $330.00	Low
11/17/2023	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$315.00 ➝ $350.00	Low
11/17/2023	HSBC	Initiated Coverage	Buy	$318.00	Low
10/23/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$330.00 ➝ $300.00	Low
10/20/2023	Piper Sandler	Lower Target	Overweight ➝ Overweight	$385.00 ➝ $325.00	Low
10/20/2023	Citigroup	Lower Target	Buy ➝ Buy	$400.00 ➝ $390.00	Low
10/20/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$355.00	Low
10/20/2023	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$386.00 ➝ $363.00	Low
10/20/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$368.00 ➝ $310.00	Low
10/19/2023	UBS Group	Lower Target	Neutral ➝ Neutral	$385.00 ➝ $314.00	Low
10/16/2023	SVB Leerink	Initiated Coverage	Outperform	$342.00	Low
8/17/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$360.00	Low
7/24/2023	Morgan Stanley	Boost Target	Equal Weight	$310.00 ➝ $330.00	Low
7/24/2023	Raymond James	Boost Target	Outperform	$323.00 ➝ $368.00	Low
7/24/2023	Barclays	Boost Target	Overweight	$314.00 ➝ $385.00	Low
7/21/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$335.00 ➝ $365.00	Low
7/21/2023	Piper Sandler	Boost Target	Overweight	$315.00 ➝ $385.00	Low
7/21/2023	Royal Bank of Canada	Boost Target	Outperform	$355.00 ➝ $360.00	Low
7/21/2023	Wells Fargo & Company	Boost Target	Overweight	$310.00 ➝ $386.00	Low
7/19/2023	Truist Financial	Boost Target		$347.00 ➝ $400.00	Low
7/18/2023	Robert W. Baird	Initiated Coverage	Outperform	$377.00	Low
7/17/2023	BTIG Research	Boost Target		$326.00 ➝ $373.00	Low
7/17/2023	Mizuho	Boost Target		$300.00 ➝ $370.00	Low
7/12/2023	Royal Bank of Canada	Boost Target		$309.00 ➝ $355.00	Low
7/10/2023	Citigroup	Boost Target		$317.00 ➝ $400.00	Low
6/5/2023	BTIG Research	Boost Target		$313.00 ➝ $326.00	Low
5/31/2023	Sanford C. Bernstein	Boost Target		$350.00 ➝ $365.00	Low
5/18/2023	Truist Financial	Boost Target		$325.00 ➝ $347.00	Low
4/20/2023	Sanford C. Bernstein	Boost Target	Outperform	$325.00 ➝ $350.00	Low
4/19/2023	Barclays	Boost Target	Overweight	$298.00 ➝ $314.00	Low
4/19/2023	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$245.00 ➝ $290.00	Low
4/19/2023	Stifel Nicolaus	Boost Target	Buy	$285.00 ➝ $315.00	Low
4/19/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$250.00 ➝ $335.00	Low
4/19/2023	Piper Sandler	Boost Target	Overweight	$265.00 ➝ $315.00	Low
4/19/2023	Royal Bank of Canada	Boost Target	Outperform	$305.00 ➝ $309.00	Low
4/19/2023	Evercore ISI	Boost Target	Inline	$240.00 ➝ $270.00	Low
4/19/2023	Morgan Stanley	Boost Target	Equal Weight	$265.00 ➝ $285.00	Low
4/19/2023	Truist Financial	Boost Target	Buy	$300.00 ➝ $325.00	Low
4/19/2023	Bank of America	Boost Target	Buy	$300.00 ➝ $315.00	Low
4/19/2023	Wells Fargo & Company	Boost Target	Overweight	$289.00 ➝ $310.00	Low
4/19/2023	Raymond James	Boost Target	Outperform	$270.00 ➝ $323.00	Low
4/19/2023	Citigroup	Boost Target	Buy	$305.00 ➝ $317.00	Low
4/18/2023	Mizuho	Boost Target	Neutral	$240.00 ➝ $250.00	Low
4/17/2023	BTIG Research	Boost Target	Buy	$279.00 ➝ $284.00	Low
4/4/2023	Evercore ISI	Boost Target	In-Line	$215.00 ➝ $240.00	Low
3/28/2023	UBS Group	Initiated Coverage	Neutral	$278.00	Low
3/23/2023	William Blair	Initiated Coverage	Outperform		Low
1/26/2023	Raymond James	Boost Target	Outperform	$255.00 ➝ $270.00	Low
1/25/2023	Morgan Stanley	Lower Target	Equal Weight	$290.00 ➝ $265.00	Low
1/25/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$230.00 ➝ $245.00	Low
1/25/2023	BTIG Research	Lower Target	Buy	$316.00 ➝ $279.00	Low
1/25/2023	Truist Financial	Lower Target	Buy	$310.00 ➝ $300.00	Low
1/25/2023	Wells Fargo & Company	Lower Target	Overweight	$305.00 ➝ $289.00	Low
1/25/2023	Mizuho	Lower Target		$245.00 ➝ $240.00	Low
1/25/2023	Citigroup	Lower Target	Buy	$318.00 ➝ $305.00	Low
1/24/2023	Mizuho	Boost Target	Neutral	$215.00 ➝ $245.00	Low
1/6/2023	Morgan Stanley	Boost Target	Equal Weight	$235.00 ➝ $290.00	Low
1/4/2023	Barclays	Boost Target		$235.00 ➝ $298.00	Low
12/22/2022	Argus	Boost Target	Buy	$265.00 ➝ $320.00	Low
12/20/2022	Truist Financial	Boost Target	Buy	$300.00 ➝ $310.00	Low
12/12/2022	Wells Fargo & Company	Boost Target	Overweight	$262.00 ➝ $305.00	Low
12/12/2022	Citigroup	Boost Target		$245.00 ➝ $318.00	Low
12/5/2022	BTIG Research	Boost Target	Buy	$247.00 ➝ $316.00	Low
11/18/2022	JPMorgan Chase & Co.	Boost Target	Overweight	$250.00 ➝ $280.00	Low
11/14/2022	Truist Financial	Boost Target		$260.00 ➝ $300.00	Low
10/20/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$205.00 ➝ $230.00	Low
10/19/2022	Morgan Stanley	Boost Target	Equal Weight	$215.00 ➝ $235.00	Low
10/19/2022	Truist Financial	Boost Target		$230.00 ➝ $260.00	Low
10/19/2022	Wells Fargo & Company	Lower Target	Overweight	$265.00 ➝ $248.00	Low
10/19/2022	Piper Sandler	Boost Target	Overweight	$260.00 ➝ $265.00	N/A
10/17/2022	Barclays	Initiated Coverage	Overweight	$235.00	Low
10/17/2022	Truist Financial	Lower Target	Buy	$255.00 ➝ $230.00	Low
10/12/2022	Mizuho	Initiated Coverage	Neutral	$215.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Hold	$210.00	Low
10/11/2022	Morgan Stanley	Lower Target	Equal Weight	$225.00 ➝ $215.00	Low
10/5/2022	Citigroup	Lower Target		$243.00 ➝ $237.00	Low
9/9/2022	Stifel Nicolaus	Boost Target	Buy	$250.00 ➝ $260.00	Low
8/18/2022	Piper Sandler	Boost Target	Overweight	$255.00 ➝ $260.00	Low
7/29/2022	The Goldman Sachs Group	Lower Target	Buy	$319.00 ➝ $273.00	Low
7/22/2022	Wells Fargo & Company	Lower Target		$265.00	Low
7/22/2022	Truist Financial	Lower Target	Buy	$270.00 ➝ $255.00	Low
7/22/2022	Evercore ISI	Lower Target		$210.00 ➝ $175.00	Low
7/22/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$225.00 ➝ $205.00	Low
7/22/2022	Raymond James	Lower Target		$294.00 ➝ $255.00	Low
7/22/2022	Piper Sandler	Lower Target	Overweight	$316.00 ➝ $255.00	Low
7/18/2022	BTIG Research	Lower Target	Buy	$355.00 ➝ $247.00	Low
7/18/2022	Stifel Nicolaus	Lower Target		$325.00 ➝ $270.00	Low
7/15/2022	Morgan Stanley	Lower Target	Equal Weight	$300.00 ➝ $225.00	Low
7/13/2022	Truist Financial	Lower Target	Buy	$355.00 ➝ $270.00	Low
6/22/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$300.00 ➝ $225.00	Low
6/3/2022	Piper Sandler	Reiterated Rating	Buy	$316.00	Low
5/17/2022	Citigroup	Lower Target		$360.00 ➝ $305.00	N/A
4/25/2022	Morgan Stanley	Lower Target	Equal Weight	$325.00 ➝ $300.00	Low
4/22/2022	Wells Fargo & Company	Lower Target	Overweight	$350.00 ➝ $339.00	High
4/22/2022	Evercore ISI	Lower Target		$294.00 ➝ $280.00	High
4/22/2022	Raymond James	Lower Target	Outperform	$334.00 ➝ $330.00	High
4/22/2022	Piper Sandler	Boost Target	Overweight	$310.00 ➝ $316.00	High
4/12/2022	Truist Financial	Initiated Coverage	Buy	$360.00	High
4/5/2022	Wolfe Research	Initiated Coverage	Peer Perform	$315.00	High
3/25/2022	Royal Bank of Canada	Initiated Coverage	Outperform	$340.00	Medium
3/1/2022	Bank of America	Initiated Coverage	Buy ➝ Buy		Medium
2/2/2022	UBS Group	Upgrade	Neutral ➝ Buy	$317.00 ➝ $325.00	Low
1/31/2022	Piper Sandler	Upgrade	Neutral ➝ Overweight	$300.00 ➝ $310.00	High
1/25/2022	Redburn Partners	Downgrade	Buy ➝ Neutral		Low
1/21/2022	BTIG Research	Lower Target	Buy	$372.00 ➝ $360.00	High
1/21/2022	Evercore ISI	Lower Target	Inline	$340.00 ➝ $290.00	High
1/21/2022	UBS Group	Lower Target	Neutral	$338.00 ➝ $317.00	High
1/21/2022	Morgan Stanley	Lower Target	Equal Weight	$375.00 ➝ $325.00	High
1/21/2022	Stifel Nicolaus	Lower Target	Buy	$370.00 ➝ $325.00	High
1/21/2022	Raymond James	Lower Target	Outperform	$383.00 ➝ $334.00	High
1/21/2022	Wells Fargo & Company	Lower Target	Overweight	$381.00 ➝ $350.00	High
1/21/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$323.00 ➝ $300.00	High
1/21/2022	Robert W. Baird	Lower Target	Outperform	$370.00 ➝ $315.00	High
1/21/2022	Citigroup	Upgrade	Neutral ➝ Buy	$370.00 ➝ $360.00	High
1/21/2022	Piper Sandler	Lower Target	Neutral	$330.00 ➝ $300.00	High
1/10/2022	BTIG Research	Upgrade	Neutral ➝ Buy	$372.00	Low
1/7/2022	Morgan Stanley	Boost Target	Equal Weight	$325.00 ➝ $375.00	Medium
12/16/2021	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		Low
10/21/2021	Morgan Stanley	Boost Target	Equal Weight	$310.00 ➝ $325.00	Low
10/20/2021	UBS Group	Boost Target	Neutral	$323.00 ➝ $352.00	High
10/20/2021	Wells Fargo & Company	Boost Target	Overweight	$354.00 ➝ $381.00	High
10/20/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$306.00 ➝ $323.00	High
10/20/2021	Robert W. Baird	Boost Target	Outperform	$350.00 ➝ $370.00	High
10/20/2021	Piper Sandler	Boost Target	Neutral	$323.00 ➝ $330.00	Medium
10/5/2021	Morgan Stanley	Lower Target	Equal Weight	$323.50 ➝ $310.00	N/A
10/1/2021	Citigroup	Downgrade	Buy ➝ Neutral	$366.67	High
9/28/2021	Raymond James	Initiated Coverage	Buy	$383.33	Low
8/26/2021	SVB Leerink	Boost Target	Market Perform	$325.00 ➝ $346.67	Medium
7/22/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$275.00 ➝ $308.33	High
7/21/2021	SVB Leerink	Boost Target	Market Perform	$310.00 ➝ $325.00	Low
7/21/2021	UBS Group	Boost Target	Neutral	$296.67 ➝ $323.33	Low
7/21/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$300.00 ➝ $333.33	Low
7/21/2021	Bank of America	Boost Target	Neutral	$296.67 ➝ $340.00	Low
7/21/2021	Evercore ISI	Boost Target	In-Line	$275.00 ➝ $326.67	High
7/21/2021	Morgan Stanley	Boost Target	Equal Weight	$285.00 ➝ $310.00	High
7/21/2021	Wells Fargo & Company	Boost Target	Positive ➝ Overweight	$305.33 ➝ $353.33	High
7/21/2021	Robert W. Baird	Boost Target	Sell ➝ Outperform	$275.00 ➝ $350.00	High
7/21/2021	Citigroup	Boost Target	Buy	$313.00 ➝ $366.67	High
7/21/2021	Piper Sandler	Boost Target	Neutral	$280.00 ➝ $323.33	High
7/14/2021	The Goldman Sachs Group	Boost Target	Buy	$317.67 ➝ $363.33	Low
7/14/2021	Stifel Nicolaus	Boost Target	Buy	$320.00 ➝ $353.33	Low
6/7/2021	Wells Fargo & Company	Boost Target	Positive ➝ Overweight	$297.33 ➝ $305.33	Low
4/21/2021	Citigroup	Boost Target		$287.33 ➝ $313.00	High
4/21/2021	Morgan Stanley	Boost Target	Equal Weight	$260.00 ➝ $285.00	High
4/21/2021	SVB Leerink	Boost Target	Market Perform	$275.00 ➝ $286.67	High
4/21/2021	Wells Fargo & Company	Boost Target	Overweight	$293.00 ➝ $297.33	High
4/21/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$230.00 ➝ $275.00	High
4/21/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$280.00 ➝ $300.00	High
4/21/2021	Piper Sandler	Boost Target	Neutral	$245.00 ➝ $280.00	High
4/21/2021	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$275.00 ➝ $308.33	High
4/21/2021	Oppenheimer	Upgrade	Underperform ➝ Market Perform		High
4/1/2021	Citigroup	Initiated Coverage	Buy	$287.33	Low
3/31/2021	Piper Sandler	Boost Target	Neutral	$243.33 ➝ $245.00	High
1/22/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$275.00 ➝ $280.00	High
1/22/2021	Raymond James	Boost Target	Outperform	$266.67 ➝ $288.33	High
1/22/2021	Wells Fargo & Company	Boost Target	Overweight	$280.33 ➝ $293.00	High
1/22/2021	Oppenheimer	Boost Target	Underperform	$121.67 ➝ $136.67	High
1/22/2021	Piper Sandler	Boost Target	Neutral	$226.67 ➝ $243.33	High
12/15/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$260.00	Medium
10/16/2020	SVB Leerink	Boost Target	Market Perform	$230.00 ➝ $241.67	High
10/16/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$255.00 ➝ $261.67	High
10/16/2020	Stifel Nicolaus	Boost Target	Buy	$241.67 ➝ $271.67	High
10/16/2020	Wells Fargo & Company	Boost Target	Overweight	$242.33 ➝ $271.67	High
10/16/2020	Morgan Stanley	Boost Target	Overweight	$245.00 ➝ $261.67	High
10/16/2020	Piper Sandler	Boost Target	Neutral	$198.33 ➝ $226.67	High
10/15/2020	BTIG Research	Reiterated Rating	Hold		High
10/12/2020	Raymond James	Boost Target	Outperform	$241.67 ➝ $266.67	High
9/28/2020	Argus	Initiated Coverage	Buy	$258.33	Medium
9/14/2020	BTIG Research	Reiterated Rating	Hold		Low
9/11/2020	Wolfe Research	Initiated Coverage	Outperform	$263.00	Low
9/8/2020	Bank of America	Downgrade	Buy ➝ Neutral	$241.67 ➝ $253.33	High
9/1/2020	Robert W. Baird	Initiated Coverage	Neutral	$233.33	High
8/14/2020	SVB Leerink	Boost Target	Market Perform	$216.67 ➝ $230.00	Low
8/3/2020	BTIG Research	Reiterated Rating	Hold		Low
7/22/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$200.00 ➝ $233.33	High
7/22/2020	UBS Group	Boost Target	Neutral	$188.33 ➝ $223.33	Medium
7/22/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$166.67 ➝ $200.00	Medium
7/22/2020	Morgan Stanley	Boost Target	Overweight	$200.67 ➝ $245.00	Medium
7/22/2020	SVB Leerink	Boost Target	Market Perform	$196.67 ➝ $216.67	Medium
7/22/2020	Raymond James	Boost Target	Outperform	$200.00 ➝ $241.67	Low
7/22/2020	Piper Sandler	Boost Target	Neutral	$170.00 ➝ $198.33	Medium
7/22/2020	Wells Fargo & Company	Boost Target	Overweight	$210.67 ➝ $242.33	Medium
7/20/2020	Sanford C. Bernstein	Boost Target	Outperform	$208.33 ➝ $241.67	Medium
7/20/2020	Stifel Nicolaus	Boost Target	Buy	$191.67 ➝ $238.33	Medium
7/15/2020	SVB Leerink	Boost Target	Market Perform	$178.33 ➝ $196.67	High
7/13/2020	Sanford C. Bernstein	Reiterated Rating	Buy	$208.33	High
6/18/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$188.33 ➝ $200.00	Low
6/16/2020	OTR Global	Downgrade	Positive		Low
6/4/2020	Wells Fargo & Company	Boost Target	Overweight	$187.00 ➝ $210.67	Medium
4/28/2020	Oppenheimer	Reiterated Rating	Sell	$121.67	High
4/28/2020	Piper Sandler	Downgrade	Overweight ➝ Neutral	$190.00 ➝ $170.00	Medium
4/19/2020	Evercore ISI	Downgrade	In-Line ➝ Underperform		Low
4/17/2020	UBS Group	Lower Target	Neutral	$206.67 ➝ $188.33	Medium
4/17/2020	Cfra	Downgrade	Hold ➝ Sell		Medium
4/17/2020	Piper Sandler	Lower Target		$211.00 ➝ $190.00	High
4/17/2020	Wells Fargo & Company	Boost Target	Overweight	$185.00 ➝ $187.00	Medium
4/17/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$198.33 ➝ $166.67	Low
4/17/2020	Stifel Nicolaus	Boost Target	Buy	$141.67 ➝ $191.67	Low
4/17/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$191.67 ➝ $178.33	Medium
4/17/2020	BTIG Research	Reiterated Rating	Hold		High
4/13/2020	Raymond James	Lower Target	Outperform	$220.00 ➝ $200.00	Low
4/9/2020	Bank of America	Reiterated Rating	Buy	$216.67	Low
4/9/2020	Evercore ISI	Downgrade	In-Line ➝ Underperform		Low
4/8/2020	Piper Sandler	Reiterated Rating	Buy	$211.00	High
4/2/2020	Wells Fargo & Company	Lower Target	Overweight	$218.33 ➝ $181.67	Medium
4/1/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium
4/1/2020	Oppenheimer	Downgrade	Market Perform ➝ Underperform	$121.67	High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$223.33 ➝ $207.33	Low
3/24/2020	Stifel Nicolaus	Lower Target	Buy	$221.67 ➝ $141.67	High
3/17/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$221.67 ➝ $191.67	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$241.67	Medium
1/27/2020	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$203.33 ➝ $198.33	Low
1/24/2020	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$191.67 ➝ $221.67	High
1/24/2020	Raymond James	Boost Target	Outperform	$205.00 ➝ $220.00	High
1/10/2020	UBS Group	Boost Target	Neutral	$196.67 ➝ $206.67	Medium
1/10/2020	Cantor Fitzgerald	Reiterated Rating	Overweight	$206.67 ➝ $230.00	Medium
12/17/2019	Morgan Stanley	Boost Target	Overweight	$206.67 ➝ $223.33	Low
12/9/2019	Wells Fargo & Company	Reiterated Rating	Overweight	$206.67 ➝ $218.33	High
11/20/2019	Oppenheimer	Initiated Coverage	Market Perform		Low
10/18/2019	Piper Sandler Companies	Set Target	Buy	$211.00	Low
10/18/2019	Royal Bank of Canada	Set Target	Hold	$190.00	Low
10/18/2019	Morgan Stanley	Set Target	Buy	$206.67	Low
10/18/2019	Wells Fargo & Company	Set Target	Buy	$206.67	Low
10/18/2019	Raymond James	Boost Target	Buy	$203.33 ➝ $208.33	Low
10/18/2019	UBS Group	Boost Target	Neutral	$186.67 ➝ $196.67	High
9/13/2019	Redburn Partners	Initiated Coverage	Buy		Low
7/19/2019	Northland Securities	Set Target	Sell	$125.00	Low
7/19/2019	Cantor Fitzgerald	Set Target	Buy	$206.67	Low
7/19/2019	Morgan Stanley	Set Target	Buy	$206.67	Low
7/19/2019	UBS Group	Set Target	Hold	$186.67	Low
7/19/2019	Piper Sandler Companies	Boost Target	Overweight	$203.33 ➝ $211.00	Medium
5/22/2019	Piper Sandler Companies	Upgrade	Overweight	$203.33	Low
5/14/2019	Citigroup	Lower Target	Buy	$203.67 ➝ $191.67	Low

(Data available from 4/26/2019 forward)

News Sentiment Rating

1.03 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

30 very positive mentions
12 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

9/29/2023

24 very positive mentions
26 positive mentions
6 negative mentions
1 very negative mentions

Mentions as of

10/29/2023

12 very positive mentions
14 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

11/28/2023

21 very positive mentions
16 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

12/28/2023

53 very positive mentions
73 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

1/27/2024

41 very positive mentions
32 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

2/26/2024

52 very positive mentions
22 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

3/27/2024

58 very positive mentions
27 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

4/26/2024

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Today's Range

Now: $375.53

$368.10

$377.83

50 Day Range

MA: $386.26

$366.34

$400.59

52 Week Range

Now: $375.53

$254.85

$403.76

Volume

263,259 shs

Average Volume

1,650,033 shs

Market Capitalization

$133.20 billion

P/E Ratio

67.79

Dividend Yield

N/A

Beta

1.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?: The following Wall Street research analysts have issued research reports on Intuitive Surgical in the last year: Barclays PLC, BTIG Research, Citigroup Inc., HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, SVB Leerink LLC, TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for ISRG.
What is the current price target for Intuitive Surgical?: 18 Wall Street analysts have set twelve-month price targets for Intuitive Surgical in the last year. Their average twelve-month price target is $396.17, suggesting a possible upside of 5.5%. Citigroup Inc. has the highest price target set, predicting ISRG will reach $462.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $314.00 for Intuitive Surgical in the next year.
View the latest price targets for ISRG.
What is the current consensus analyst rating for Intuitive Surgical?: Intuitive Surgical currently has 4 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ISRG.
What other companies compete with Intuitive Surgical?: Other companies that are similar to Intuitive Surgical include Edwards Lifesciences, Stryker, Elevance Health, Sanofi and Amgen. Learn More about companies similar to Intuitive Surgical.
How do I contact Intuitive Surgical's investor relations team?: Intuitive Surgical's physical mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider's listed phone number is (408) 523-2100 and its investor relations email address is [email protected]. The official website for Intuitive Surgical is www.intuitive.com. Learn More about contacing Intuitive Surgical investor relations.

Intuitive Surgical - ISRG Stock Price Target and Predictions

Analyst Price Target for ISRG

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

1.03 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?

What is the current price target for Intuitive Surgical?

What is the current consensus analyst rating for Intuitive Surgical?

What other companies compete with Intuitive Surgical?

How do I contact Intuitive Surgical's investor relations team?